Skip to content

Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)

Effect of Helicobacter Pylori Treatment on Remission of Idiopathic Central Serous Chorioretinopathy (ICSCR)

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00817245
Acronym
ICSCR
Enrollment
50
Registered
2009-01-06
Start date
2008-03-31
Completion date
2009-01-31
Last updated
2009-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Serous Chorioretinopathy

Keywords

CSR, Helicobacter pylori

Brief summary

Etiology of ICSCR is not known however recent studies regard the role of immunologic and infectious processes in the pathogenesis of ICSCR.one of these hypothesis is the role of helicobacter pylori in the pathogenesis of ICSCR so perhaps treatment of h pylori have positive effect on the remission of ICSCR.

Detailed description

we will choose 50 cases of patients with ICSCR who are infected with h.pylori.25 cases will receive anti h.pylori regiment and 25 cases as controls will receive no medication.then we will compare the time of submacular fluid resorption and macular thickness and visual acuity among these two groups.

Interventions

DRUGomeprazole, Amoxicillin, metronidazole

we will evaluate the effect of medication(anti h.pylori) on the remission of ICSCR

Sponsors

Tabriz University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
28 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* the persons who are infected with helicobacter pylori and have ICSCR

Exclusion criteria

* history of previous eye surgery ,to have indication of laser therapy,corticosteroid therapy,pregnancy,

Design outcomes

Primary

MeasureTime frame
Subretinal fluid level

Secondary

MeasureTime frame
time of sub macular fluid absorption

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026